|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
357,741,000 |
Market
Cap: |
133.31(B) |
Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
52
Week Range: |
$258.49 - $400.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1071 |
Guru Rank Value : -4.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
21,047 |
282,612 |
397,629 |
792,484 |
Total Sell Value |
$8,159,111 |
$108,998,780 |
$143,770,834 |
$244,205,489 |
Total People Sold |
7 |
12 |
13 |
13 |
Total Sell Transactions |
19 |
43 |
55 |
85 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Miller Brian Edward |
EVP & Chief Digital Officer |
|
2024-02-10 |
4 |
D |
$388.22 |
$189,063 |
D/D |
(487) |
9,782 |
|
- |
|
Miller Brian Edward |
EVP & Chief Digital Officer |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,317 |
10,269 |
|
- |
|
Charlton Henry L |
SVP & Chief Commercial and Mkt |
|
2024-02-10 |
4 |
D |
$388.22 |
$131,218 |
D/D |
(338) |
21,365 |
|
- |
|
Charlton Henry L |
SVP & Chief Commercial and Mkt |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,078 |
21,703 |
|
- |
|
Brosius Mark |
See Remarks |
|
2024-02-10 |
4 |
D |
$388.22 |
$164,994 |
D/D |
(425) |
861 |
|
- |
|
Brosius Mark |
See Remarks |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
838 |
1,286 |
|
- |
|
Guthart Gary S |
CEO |
|
2024-02-10 |
4 |
D |
$388.22 |
$518,274 |
D/D |
(1,335) |
10,724 |
|
- |
|
Guthart Gary S |
CEO |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,634 |
12,059 |
|
- |
|
Rosa David J. |
President |
|
2024-02-07 |
4 |
AS |
$389.23 |
$31,418,468 |
D/D |
(80,710) |
214,389 |
|
- |
|
Rosa David J. |
President |
|
2024-02-07 |
4 |
OE |
$49.09 |
$7,375,967 |
D/D |
140,850 |
230,089 |
|
- |
|
Miller Brian Edward |
EVP & Chief Digital Officer |
|
2024-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,952 |
|
- |
|
Brosius Mark |
See Remarks |
|
2024-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
487 |
|
- |
|
Brosius Mark |
SVP & Chief Mfg and Supply Cha |
|
2024-02-01 |
4 |
AS |
$378.41 |
$14,758 |
D/D |
(39) |
448 |
|
- |
|
Guthart Gary S |
CEO |
|
2024-01-29 |
4 |
AS |
$374.41 |
$1,857,074 |
I/I |
(4,960) |
27,360 |
|
- |
|
Guthart Gary S |
CEO |
|
2024-01-29 |
4 |
AS |
$376.06 |
$9,147,669 |
D/D |
(24,325) |
9,425 |
|
- |
|
Guthart Gary S |
CEO |
|
2024-01-29 |
4 |
OE |
$51.02 |
$1,721,777 |
D/D |
33,750 |
33,750 |
|
- |
|
Johnson Amal M |
Director |
|
2024-01-26 |
4 |
AS |
$370.08 |
$2,478,032 |
D/D |
(6,696) |
11,706 |
|
- |
|
Johnson Amal M |
Director |
|
2024-01-26 |
4 |
OE |
$56.97 |
$381,501 |
D/D |
6,696 |
18,402 |
|
- |
|
Levy Alan J |
Director |
|
2024-01-26 |
4 |
AS |
$370.20 |
$740,405 |
D/D |
(2,000) |
25,319 |
|
- |
|
Levy Alan J |
Director |
|
2024-01-26 |
4 |
OE |
$90.49 |
$185,578 |
D/D |
2,000 |
27,247 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2024-01-26 |
4 |
AS |
$370.15 |
$1,598,298 |
D/D |
(4,318) |
189 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2024-01-26 |
4 |
OE |
$177.99 |
$775,816 |
D/D |
4,318 |
1,689 |
|
- |
|
Rosa David J. |
President |
|
2023-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,572 |
154,140 |
|
- |
|
Johnson Amal M |
Director |
|
2023-11-16 |
4 |
AS |
$300.00 |
$2,870,100 |
D/D |
(9,567) |
11,706 |
|
- |
|
Johnson Amal M |
Director |
|
2023-11-16 |
4 |
OE |
$41.26 |
$394,713 |
D/D |
9,567 |
21,273 |
|
- |
|
1371 Records found
|
|
Page 6 of 55 |
|
|